Research Article

Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis

Table 3

The information of top 20 common targets.

GeneProteinUniProt IDDegreeBetweenness centralityCloseness centralityNeighborhood connectivity

IL6Interleukin-6P0523193667.99304020.83333333389.12839505
GAPDHGlyceraldehyde-3-phosphate dehydrogenaseP0440691719.08411930.81560283785.92631575
VEGFAVascular endothelial growth factor AP1569289413.57539550.79310344884.52425102
TNFTumor necrosis factorP0137589335.49344030.79861111184.68661002
AKT1RAC-alpha serine/threonine-protein kinaseP3174987524.26087820.79861111180.85548315
MAPK3Mitogen-activated protein kinase 3P2736184410.46232040.77702702776.40073952
TP53Cellular tumor antigen p53P0463781307.21389650.74675324773.70696197
CXCL8Interleukin-8P1014578218.28939640.73248407670.86636431
PTGS2Prostaglandin G/H synthase 2P3535478206.01684620.73717948769.98848441
EGFProepidermal growth factorP0113376261.85699340.73717948765.03746714
MMP9Matrix metalloproteinase-9P1478076433.88061290.7187568.81580781
CCL2C-C motif chemokine 2P1350075157.42141880.7232704467.00969048
IL10Interleukin-10P2230174145.5842670.7187565.80203946
IL1βInterleukin-1 betaP0158474158.0143360.7187565.60821648
MAPK8Mitogen-activated protein kinase 8P4598373129.3554710.70987654365.62343779
JUNTranscription factor AP-1P0541273122.19608420.70987654366.15527831
CASP3Caspase-3P4257472107.3863970.70121951264.73650484
MAPK1Mitogen-activated protein kinase 1P2848271166.11619840.70552147261.56264833
MYCMyc proto-oncogene proteinP0110664147.98514830.6725146254.86995265
MMP272 kDa type IV collagenaseP082536274.827925540.6609195452.92741783